Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement
Open Access
- 10 August 2024
- journal article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 35 (2) , 103712
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery DiseaseCurrent Cardiology Reports, 2023
- Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study ProtocolHigh Blood Pressure & Cardiovascular Prevention, 2023
- Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsJAMA, 2023
- Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2023
- Determinants of Functional Improvement After Cardiac Rehabilitation in Acute Coronary SyndromeHigh Blood Pressure & Cardiovascular Prevention, 2021
- Is the 2020 Sampson equation the best formula for LDL-C estimation?European Journal of Internal Medicine, 2021
- Predictors of cardiac rehabilitation referral, enrolment and completion after acute myocardial infarction: an exploratory studyNetherlands Heart Journal, 2020
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke SubtypesJAMA Neurology, 2020
- Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk RecognitionCurrent Diabetes Reports, 2019
- Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot studyClinical Cardiology, 2018